(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 2.94%62.49B | 4.93%30.58B | 1.05%124.25B | -3.42%89.39B | 1.48%60.7B | 4.34%29.14B | 7.36%122.95B | 10.42%92.56B | 12.71%59.82B | 6.43%27.93B |
Operating income | 2.94%62.49B | 4.93%30.58B | 1.05%124.25B | -3.42%89.39B | 1.48%60.7B | 4.34%29.14B | 7.36%122.95B | 10.42%92.56B | 12.71%59.82B | 6.43%27.93B |
Operating expenses | -7.92%-37.2B | -9.60%-17.73B | 5.93%-72.65B | 13.06%-50.35B | 8.48%-34.47B | 6.92%-16.18B | -4.14%-77.23B | -9.36%-57.92B | -11.12%-37.66B | -2.57%-17.38B |
Gross profit | -3.61%25.29B | -0.91%12.85B | 12.85%51.6B | 12.70%39.04B | 18.42%26.24B | 22.89%12.97B | 13.29%45.73B | 12.23%34.64B | 15.52%22.16B | 13.48%10.55B |
Selling expenses | 9.29%-4.19B | 6.27%-2.04B | -10.89%-10.17B | -0.53%-6.9B | -4.36%-4.62B | -1.05%-2.17B | -5.04%-9.17B | -6.72%-6.86B | -6.09%-4.42B | 0.64%-2.15B |
Administrative expenses | 11.09%-2.24B | 13.72%-1.14B | -5.61%-5.63B | 2.39%-3.81B | 0.67%-2.52B | -3.28%-1.32B | 2.05%-5.33B | 4.36%-3.9B | 0.43%-2.53B | -2.12%-1.28B |
Research and development expenses | 0.51%-12.73B | -7.46%-6.38B | -17.07%-25.29B | -18.33%-19.06B | -26.00%-12.79B | -26.29%-5.93B | -14.88%-21.6B | -13.67%-16.11B | -14.56%-10.15B | -12.07%-4.7B |
Profit from asset sales | 309.22%67.37M | -50.84%3.86M | 86.75%20.6M | 167.05%20.3M | 116.55%16.46M | --7.84M | -95.24%11.03M | -83.99%7.6M | -83.99%7.6M | ---- |
Revaluation surplus | 3.35%-416.54M | 35.62%-171.3M | 38.50%-702.28M | 84.05%-178.66M | -9.88%-430.99M | -19.24%-266.05M | -203.86%-1.14B | -236.18%-1.12B | -144.84%-392.23M | -466.66%-223.12M |
-Changes in the fair value of other assets | 3.35%-416.54M | 35.62%-171.3M | 38.50%-702.28M | 84.05%-178.66M | -9.88%-430.99M | -19.24%-266.05M | -203.86%-1.14B | -236.18%-1.12B | -144.84%-392.23M | -466.66%-223.12M |
Impairment and provision | -15.50%-525.87M | 19.76%-410.97M | 40.09%-934.16M | -44.71%-1.2B | -63.97%-455.31M | -400.76%-512.2M | 12.90%-1.56B | -80.11%-829M | -229.32%-277.68M | 21.87%-102.29M |
-Other impairment is provision | -15.50%-525.87M | 19.76%-410.97M | 40.09%-934.16M | -44.71%-1.2B | -63.97%-455.31M | -400.76%-512.2M | 12.90%-1.56B | -80.11%-829M | -229.32%-277.68M | 21.87%-102.29M |
Special items of operating profit | 205.33%1.62B | 35.47%724.9M | -46.29%1.6B | -73.94%684.21M | -66.32%529.66M | -10.12%535.1M | -14.98%2.98B | 7.56%2.63B | -20.19%1.57B | -59.02%595.35M |
Operating profit | 19.57%6.32B | 7.56%3.15B | 2.22%9.16B | -2.92%7.63B | -5.06%5.29B | 18.38%2.93B | -7.06%8.96B | -7.47%7.86B | -7.56%5.57B | -15.83%2.48B |
Financing cost | -105.69%-46.31M | -64.86%63.79M | 774.72%1.1B | 391.42%887.3M | 367.91%813.75M | 442.03%181.54M | 83.05%-163.21M | 61.50%-304.48M | 36.81%-303.75M | 85.98%-53.08M |
Special items of earning before tax | 99.23%-333K | 59.00%-9.51M | -27.93%-55.24M | -28.05%-55.49M | 21.54%-43.39M | -227.93%-23.2M | 75.63%-43.18M | 12.87%-43.33M | -195.06%-55.3M | 162.44%18.14M |
Earning before tax | 3.60%6.28B | 3.80%3.21B | 16.59%10.2B | 12.64%8.46B | 16.26%6.06B | 26.56%3.09B | 2.97%8.75B | -1.85%7.51B | -5.70%5.21B | -3.67%2.44B |
Tax | 15.03%-566.79M | 6.31%-445.61M | -0.23%-962.29M | 14.22%-704.56M | -0.31%-667.09M | -17.02%-475.6M | 34.38%-960.05M | 43.85%-821.34M | 31.88%-665.06M | 9.71%-406.41M |
After-tax profit from continuing operations | 5.90%5.71B | 5.64%2.76B | 18.60%9.24B | 15.94%7.76B | 18.60%5.39B | 28.46%2.61B | 10.74%7.79B | 8.07%6.69B | -0.09%4.55B | -2.37%2.03B |
Earning after tax | 5.90%5.71B | 5.64%2.76B | 18.60%9.24B | 15.94%7.76B | 18.60%5.39B | 28.46%2.61B | 10.74%7.79B | 8.07%6.69B | -0.09%4.55B | -2.37%2.03B |
Minority profit | 72.40%-22.06M | 170.95%20.21M | 70.59%-84.9M | 34.99%-84.35M | -316.72%-79.9M | 84.35%-28.48M | -229.48%-288.69M | -138.44%-129.75M | -104.06%-19.17M | -86.36%-182M |
Profit attributable to shareholders | 4.76%5.73B | 3.74%2.74B | 15.41%9.33B | 14.97%7.84B | 19.85%5.47B | 19.20%2.64B | 18.60%8.08B | 16.52%6.82B | 11.95%4.57B | 1.60%2.22B |
Basic earnings per share | 4.35%1.2 | 1.79%0.57 | 14.62%1.96 | 14.58%1.65 | 19.79%1.15 | 19.15%0.56 | 16.33%1.71 | 14.29%1.44 | 9.09%0.96 | 0.00%0.47 |
Diluted earnings per share | 4.35%1.2 | 1.79%0.57 | 14.62%1.96 | 14.58%1.65 | 19.79%1.15 | 19.15%0.56 | 16.33%1.71 | 14.29%1.44 | 9.09%0.96 | 0.00%0.47 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data